Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patients with type 1 diabetes Initial efforts will ...

Sana Biotechnology (SANA) is back in focus after Mayo Clinic agreed to collaborate on SC451 for type 1 diabetes and invest up to US$50 million, linking clinical expertise with fresh capital support.

Sana Biotechnology (SANA) stock jumps as the company partners with Mayo Clinic for type 1 diabetes therapy SC451. Read more ...

Sana Biotechnology's novel T1D treatment, not requiring immunosuppression, shows encouraging results in a non-human primate study. Sana displays improved Q3 financials with a current ratio of 4.03, ...

Investors eyeing a purchase of Sana Biotechnology Inc (Symbol: SANA) shares, but tentative about paying the going market price of $4.17/share, might benefit from considering selling puts among the ...

TWICE’s Sana has participated in a photo shoot with Cosmopolitan Korea! In 2021, TWICE had numerous music releases that were met with much global success, including their third studio album “Formula ...

Sana's first-in-human study shows HIP technology allows islet cells to avoid immune rejection and produce insulin without immunosuppression. Reliance on initial results: The press release heavily ...

AUSTIN, Texas--(BUSINESS WIRE)--Sana, a health care company that provides health benefits to small businesses at affordable prices, today announced the closing of a $60 million Series B funding round, ...

Sana Biotechnology has become the latest cell therapy biotech to shift resources from cancer to autoimmune diseases as part of a strategic refocus that sounds likely to include a side order of layoffs ...